Ruiqi Liu

State Key Laboratory Of Oncology In South China, 651 Dongfeng Road East
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

USP15-mediated deubiquitination of FIS1 impairs mitochondrial function and sensitizes bladder cancer cells to radiotherapy.

USP15-mediated deubiquitination of FIS1 impairs mitochondrial function and sensitizes bladder cancer cells to radiotherapy.

Journal: Oncogene
Published: October 27, 2025

Auto-Segmentation and Auto-Planning in Automated Radiotherapy for Prostate Cancer.

Auto-Segmentation and Auto-Planning in Automated Radiotherapy for Prostate Cancer.

Journal: Bioengineering (Basel, Switzerland)
Published: April 28, 2025

Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma.

Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 22, 2024

Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?

Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?

Journal: Translational andrology and urology
Published: September 13, 2024

Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.

Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.

Journal: Cancer research
Published: May 23, 2024

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Journal: International immunopharmacology
Published: May 08, 2024

Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.

Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.

Journal: Cancer immunology, immunotherapy : CII
Published: May 05, 2024

Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.

Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.

Journal: Clinical and translational medicine
Published: December 26, 2023

A "One Arrow Three Eagle" Strategy to Improve CM-272 Primed Bladder Cancer Immunotherapy.

A "One Arrow Three Eagle" Strategy to Improve CM-272 Primed Bladder Cancer Immunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 10, 2023

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Journal: Clinical genitourinary cancer
Published: September 01, 2023

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Journal: Therapeutic advances in medical oncology
Published: July 11, 2023

EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.

EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.

Journal: Cancer letters
Published: June 26, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026